Importantly, we identified G3BP1 as the direct target of USP21 and investigated that USP21-regulated deubiquitination and stabilization of G3BP1 were required for the activation of Wnt/β-Catenin signaling and ESCC progression. The gene discussed is USP21; the disease is esophageal squamous cell carcinoma.